Description
The examination includes the determination of major autoimmune antibodies in the blood detected in early (juvenile) rheumatoid arthritis. It can be used for diagnosing the disease at early stages of its development, as well as for monitoring therapy and predicting relapses.
The examination includes:
Anti-cyclic citrullinated peptide antibodies, IgG
Anti-keratin antibodies (AKA)
Anti-perinuclear factor
Period of execution
Within 10 days
Biomaterial type